Every international cannabis operator eventually encounters the same uncomfortable reality: the traceability system that keeps you compliant in one country can…
Read MoreEU-GMP Certification for Cannabis: The Complete 2026 Guide for International Producers
Cannabis is, by volume, one of the fastest-growing pharmaceutical commodity imports in the European Union. Germany’s medical cannabis consumption reached 142…
Read MoreThe Global Medical Cannabis Market: From $30.6B in 2025 to $159B by 2033
The global medical cannabis market is no longer a niche sector. As of 2025, more than 50 countries have enacted legal frameworks permitting some form of…
Read MoreLuxembourg’s Home Grow Model: What 4 Plants Per Household Means for European Cannabis Policy
When Luxembourg’s Law of 10 July 2023 entered into force on 21 July 2023, it was easy to read as a minor footnote in a year dominated by Germany’s landmark…
Read MoreAfrica’s Cannabis Frontier: South Africa’s Permit Landscape and Lesotho’s Export Ambitions
Africa’s cannabis story is being written from two flanks simultaneously. In Pretoria, a multi-departmental government machine is turning a National Cannabis…
Read MoreBrazil Opens the Export Door: ANVISA Authorizes Medicinal Cannabis IFA Exports Under RDC 1.023/2026
Brazil’s ANVISA has published RDC 1.023/2026, authorizing the export of medicinal-cannabis active pharmaceutical ingredients (IFAs) produced in Brazil. Here is what it means for producers.
Read More